nNOS polymorphisms are associated with responsiveness to sildenafil in clinical and postoperative erectile dysfunction

Sildenafil potentiates the nitric oxide (NO) signaling pathway. Since neuronal NOS is very important in the penis, we assessed whether polymorphisms are associated with altered responsiveness to sildenafil in erectile dysfunction (ED). Patients (n = 137) were divided as clinical ED or postoperative...

Full description

Saved in:
Bibliographic Details
Published inPharmacogenomics Vol. 15; no. 6; pp. 775 - 784
Main Authors Lacchini, Riccardo, Muniz, Jaqueline J, Nobre, Yuri TDA, Cologna, Adauto J, Martins, Antonio CP, Tanus-Santos, Jose E
Format Journal Article
LanguageEnglish
Published England Future Medicine Ltd 01.04.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sildenafil potentiates the nitric oxide (NO) signaling pathway. Since neuronal NOS is very important in the penis, we assessed whether polymorphisms are associated with altered responsiveness to sildenafil in erectile dysfunction (ED). Patients (n = 137) were divided as clinical ED or postoperative ED. They were subdivided as good responders or poor responders to sildenafil, and genotypes for rs41279104 and rs2682826 polymorphisms were determined. We found that the rs41279104 CT genotype was associated with good responders in postoperative ED patients, while rs2682826 CT genotype was associated with good responders in postoperative ED, and the TT genotype associated with good responders in both groups. Finally, the CT haplotype was associated with good responders in postoperative ED. polymorphisms are associated with responsiveness to sildenafil in ED. Original submitted 20 November 2013; Revision submitted 31 January 2014
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1462-2416
1744-8042
DOI:10.2217/pgs.14.30